Danaher (DHR) Diagnostics and Danaher Ventures, two subsidiaries of Danaher Corporation, announced that they have formed an investment partnership with Innovaccer Inc., a healthcare artificial intelligence company. “Innovaccer has built a suite of software solutions designed to create a unified patient record to identify gaps in care and patients at risk, as well as appropriate interventions to improve patient outcomes. As part of the investment partnership, Danaher, along with Innovaccer and its network of healthcare systems, seeks to accelerate the adoption of precision diagnostics both by clinicians and population health teams, facilitating value-based care,” the company stated. Julie Sawyer Montgomery, Executive Vice President, Danaher, added: “Patients are at the center of everything we do at Danaher. We believe our investment partnership with Innovaccer will empower patients and speed the transition to more personalized, value-based medicine by providing healthcare providers with the data and analytics needed to drive meaningful clinical insights, more quickly, and at the point of need.”
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DHR:
- Danaher price target lowered to $285 from $305 at Citi
- Danaher price target lowered to $268 from $278 at Evercore ISI
- Pony AI, Thermo Fisher initiated: Wall Street’s top analyst calls
- Scotiabank starts coverage on large cap life science tools trio
- Danaher initiated with a Sector Perform at Scotiabank